Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1969 1
1975 3
1976 1
1977 3
1978 1
1979 2
1980 5
1981 8
1982 9
1983 9
1984 11
1985 17
1986 13
1987 19
1988 23
1989 24
1990 20
1991 21
1992 31
1993 35
1994 27
1995 31
1996 39
1997 41
1998 61
1999 61
2000 65
2001 57
2002 81
2003 73
2004 102
2005 120
2006 154
2007 160
2008 202
2009 227
2010 268
2011 299
2012 342
2013 368
2014 445
2015 515
2016 498
2017 511
2018 659
2019 679
2020 826
2021 897
2022 612
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

7,850 results
Results by year
Filters applied: . Clear all
Page 1
Two Phase 3 Trials of Baricitinib for Alopecia Areata.
King B, Ohyama M, Kwon O, Zlotogorski A, Ko J, Mesinkovska NA, Hordinsky M, Dutronc Y, Wu WS, McCollam J, Chiasserini C, Yu G, Stanley S, Holzwarth K, DeLozier AM, Sinclair R; BRAVE-AA Investigators. King B, et al. Among authors: yu g. N Engl J Med. 2022 May 5;386(18):1687-1699. doi: 10.1056/NEJMoa2110343. Epub 2022 Mar 26. N Engl J Med. 2022. PMID: 35334197 Clinical Trial.
Ultrasensitive Ribo-seq reveals translational landscapes during mammalian oocyte-to-embryo transition and pre-implantation development.
Xiong Z, Xu K, Lin Z, Kong F, Wang Q, Quan Y, Sha QQ, Li F, Zou Z, Liu L, Ji S, Chen Y, Zhang H, Fang J, Yu G, Liu B, Wang L, Wang H, Deng H, Yang X, Fan HY, Li L, Xie W. Xiong Z, et al. Among authors: yu g. Nat Cell Biol. 2022 Jun;24(6):968-980. doi: 10.1038/s41556-022-00928-6. Epub 2022 Jun 13. Nat Cell Biol. 2022. PMID: 35697785
Inhaled mRNA Nanoformulation with Biogenic Ribosomal Protein Reverses Established Pulmonary Fibrosis in a Bleomycin-Induced Murine Model.
Zhang R, Jing W, Chen C, Zhang S, Abdalla M, Sun P, Wang G, You W, Yang Z, Zhang J, Tang C, Du W, Liu Y, Li X, Liu J, You X, Hu H, Cai L, Xu F, Dong B, Liu M, Qiang B, Sun Y, Yu G, Wu J, Zhao K, Jiang X. Zhang R, et al. Among authors: yu g. Adv Mater. 2022 Apr;34(14):e2107506. doi: 10.1002/adma.202107506. Epub 2022 Mar 1. Adv Mater. 2022. PMID: 35146813
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Wang J, Zhou C, Yao W, Wang Q, Min X, Chen G, Xu X, Li X, Xu F, Fang Y, Yang R, Yu G, Gong Y, Zhao J, Fan Y, Liu Q, Cao L, Yao Y, Liu Y, Li X, Wu J, He Z, Lu K, Jiang L, Hu C, Zhao W, Zhang B, Shi W, Zhang X, Cheng Y; CAPSTONE-1 Study Group. Wang J, et al. Among authors: yu g. Lancet Oncol. 2022 Jun;23(6):739-747. doi: 10.1016/S1470-2045(22)00224-8. Epub 2022 May 13. Lancet Oncol. 2022. PMID: 35576956 Clinical Trial.
Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study.
Shen L, Kato K, Kim SB, Ajani JA, Zhao K, He Z, Yu X, Shu Y, Luo Q, Wang J, Chen Z, Niu Z, Zhang L, Yi T, Sun JM, Chen J, Yu G, Lin CY, Hara H, Bi Q, Satoh T, Pazo-Cid R, Arkenau HT, Borg C, Lordick F, Li L, Ding N, Tao A, Shi J, Van Cutsem E; RATIONALE-302 Investigators. Shen L, et al. Among authors: yu g. J Clin Oncol. 2022 Apr 20:JCO2101926. doi: 10.1200/JCO.21.01926. Online ahead of print. J Clin Oncol. 2022. PMID: 35442766
Emotional Contagion in the Online Depression Community.
Tang J, Yu G, Yao X. Tang J, et al. Among authors: yu g. Healthcare (Basel). 2021 Nov 23;9(12):1609. doi: 10.3390/healthcare9121609. Healthcare (Basel). 2021. PMID: 34946335 Free PMC article.
7,850 results